Angiographic Outcome of Coronary Artery Bypass Grafts: The Radial Artery Database International Alliance.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
03 2020
Historique:
received: 10 02 2019
revised: 04 06 2019
accepted: 01 07 2019
pubmed: 31 8 2019
medline: 8 5 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

We used a large patient-level data set including 6 angiographic randomized controlled trials (RCTs) on coronary artery bypass conduits to explore incidence and determinants of coronary graft failure. Patient-level angiographic data of 6 RCTs comparing long-term outcomes of the radial artery and other conduits were joined. Primary outcome was graft occlusion at maximum follow-up. The analysis was divided as (1) left anterior descending coronary (LAD) distribution and (2) non-LAD distribution (circumflex and right coronary artery). Mixed-model multivariable Cox regression including all baseline characteristics with stratification by individual trials was used to identify predictors of graft occlusion. Included were 1091 patients and 2281 grafts, consisting of 921 left internal mammary arteries, 74 right internal mammary arteries, 710 radial arteries, and 576 saphenous veins. All left internal mammary arteries were used on the LAD, the other conduits were used on the non-LAD distribution. Mean angiographic follow up was 65 ± 29 months. Occlusion rates were 2.3% for the left internal mammary arteries, 13.5% for the left internal mammary arteries, 9.4% for the right internal mammary arteries, and 17.5% for the saphenous veins. At multivariable analysis, type of conduit used, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft were significantly associated with graft occlusion in the non-LAD distribution. Our analyses showed that failure of the left internal mammary arteries-to-LAD bypass is a very uncommon event. For the non-LAD distribution, the nonuse of radial artery, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft configuration were significantly associated with midterm graft failure.

Sections du résumé

BACKGROUND
We used a large patient-level data set including 6 angiographic randomized controlled trials (RCTs) on coronary artery bypass conduits to explore incidence and determinants of coronary graft failure.
METHODS
Patient-level angiographic data of 6 RCTs comparing long-term outcomes of the radial artery and other conduits were joined. Primary outcome was graft occlusion at maximum follow-up. The analysis was divided as (1) left anterior descending coronary (LAD) distribution and (2) non-LAD distribution (circumflex and right coronary artery). Mixed-model multivariable Cox regression including all baseline characteristics with stratification by individual trials was used to identify predictors of graft occlusion.
RESULTS
Included were 1091 patients and 2281 grafts, consisting of 921 left internal mammary arteries, 74 right internal mammary arteries, 710 radial arteries, and 576 saphenous veins. All left internal mammary arteries were used on the LAD, the other conduits were used on the non-LAD distribution. Mean angiographic follow up was 65 ± 29 months. Occlusion rates were 2.3% for the left internal mammary arteries, 13.5% for the left internal mammary arteries, 9.4% for the right internal mammary arteries, and 17.5% for the saphenous veins. At multivariable analysis, type of conduit used, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft were significantly associated with graft occlusion in the non-LAD distribution.
CONCLUSIONS
Our analyses showed that failure of the left internal mammary arteries-to-LAD bypass is a very uncommon event. For the non-LAD distribution, the nonuse of radial artery, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft configuration were significantly associated with midterm graft failure.

Identifiants

pubmed: 31470012
pii: S0003-4975(19)31226-3
doi: 10.1016/j.athoracsur.2019.07.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-694

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Mario Gaudino (M)

Department of Cardiothoracic Surgery, Cornell Medicine, New York, New York. Electronic address: mfg9004@med.cornell.edu.

Umberto Benedetto (U)

Department of Cardiac Surgery, Bristol Heart Institute, Bristol, United Kingdom.

Stephen E Fremes (SE)

Department of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

David L Hare (DL)

Department of Cardiology, University of Melbourne, Melbourne, Victoria, Australia; Heart Failure Services, The Austin Hospital, Melbourne, Victoria, Australia.

Philip Hayward (P)

Department of Cardiology, University of Melbourne, Melbourne, Victoria, Australia.

Neil Moat (N)

Cardiac Surgery Department, Royal Brompton & Harefield Trust, London, United Kingdom.

Marco Moscarelli (M)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Antonino Di Franco (A)

Department of Cardiothoracic Surgery, Cornell Medicine, New York, New York.

Giuseppe Nasso (G)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Miodrag Peric (M)

Institute for Cardiovascular Diseases, Dedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.

Ivana Petrovic (I)

Institute for Cardiovascular Diseases, Dedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.

Peter Collins (P)

Department of Cardiac Surgery, National Heart & Lung Institute, Imperial College London, London, United Kingdom.

Carolyn M Webb (CM)

Department of Cardiac Surgery, National Heart & Lung Institute, Imperial College London, London, United Kingdom.

John D Puskas (JD)

Icahn School of Medicine at Mount Sinai, New York, New York.

Giuseppe Speziale (G)

Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.

Kyung Jong Yoo (KJ)

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.

Leonard N Girardi (LN)

Department of Cardiothoracic Surgery, Cornell Medicine, New York, New York.

David P Taggart (DP)

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH